pathology microbiology and immunology Archives
Restricting HIV-1 infection
Sep. 1, 2017—Vanderbilt researchers are discovering ways that host proteins block HIV-1 infection, which could suggest new avenues for treatment.
Investigators use light to kill microbial ‘vampires’
Jul. 27, 2017—On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group’s latest paper in a tweet: “If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight.”
Probing the genetics of autoimmunity
Jul. 21, 2017—Vanderbilt researchers have found that non-coding regions of the genome appear to contribute to the risk of autoimmune diseases and may represent attractive therapeutic targets.
Immune responses linked to cell’s recycling system
Jul. 20, 2017—Autophagy is the cellular equivalent of trash pickup and recycling — it is a process by which proteins, protein aggregates and damaged cellular organelles are degraded in order to reuse nutrients and promote cellular metabolism.
New institute to focus on immune system
Jun. 29, 2017—Vanderbilt University Medical Center (VUMC) is launching a new institute to coordinate initiatives among the rapidly evolving disciplines of infection biology, immunology and inflammatory diseases.
Team investigates antiviral that inhibits SARS, MERS
Jun. 29, 2017—A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.
Flip side of gut protection
Jun. 9, 2017—Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.
Aronoff elected to microbiology academy
Apr. 27, 2017—Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.
Pathologist Rauch relishes opportunities to help
Apr. 13, 2017—Pathologist Carol Rauch, M.D., Ph.D., likes being prepared.
Discussing retroviruses
Mar. 16, 2017—The Rockefeller University’s Paul Bieniasz, Ph.D., center, here with Vanderbilt’s Samuel Santoro, Ph.D., left, and Christopher Aiken, Ph.D., discussed his research on retroviruses at his recent Flexner Discovery Lecture, which was sponsored by the Department of Pathology, Microbiology and Immunology.
Clinical investigation society lauds impact of Crowe’s research
Mar. 2, 2017—James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists.
Retroviruses expert Bieniasz set for next Discovery Lecture
Mar. 2, 2017—Paul Bieniasz, Ph.D., a pioneer in the study of retroviruses, will deliver the next Flexner Discovery Lecture on Thursday, March 9.
